Biomimetic total synthesis of meiogynin A, an inhibitor of Bcl-xL and bak interaction

Journal of Organic Chemistry

Volumn 75, Issue 21, 2010, Pages 7412-7415

  Fotsop, Dalia Fomekong ^a   Roussi, Fanny ^a   Leverrier, Aurélie ^a   Bretéché, Anne ^a   Guéritte, Françoise ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABSOLUTE CONFIGURATION; ANTI-APOPTOTIC PROTEIN; NATURAL COMPOUNDS; SELECTIVE SYNTHESIS; TOTAL SYNTHESIS;

ISOMERS;

BIOMIMETICS;

ANTINEOPLASTIC AGENT; MEIOGYNIN A; PROTEIN BAK; PROTEIN BCL XL; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BIOMIMETICS; DRUG POTENCY; DRUG SYNTHESIS; ISOMER; PROTEIN PROTEIN INTERACTION;

BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-X PROTEIN; BIOMIMETICS; ISOMERISM; PROTEIN BINDING; SESQUITERPENES;

EID: 78049498581     PISSN: 00223263     EISSN: 15206904     Source Type: Journal    
DOI: 10.1021/jo101088h     Document Type: Article

References (26)

1. Lowe, S. W.; Cepero, E.; Evan, G. Nature 2004, 432, 307-315
2. Letai, A. G. Nature Rev. Cancer 2008, 8, 121-132
3. Litaudon, M.; Bousserouel, H.; Awang, K.; Nosjean, O.; Martin, M.-T.; Tran Huu Dau, M. E.; Hadi, H. A.; Boutin, J. A.; Sévenet, T.; Guéritte, F. J. Nat. Prod. 2009, 72, 480-483
4. Hagiwara, H.; Okabe, T.; Ono, H.; Kamat, V. P.; Hoshi, T.; Suzuki, T.; Ando, M. J. Chem. Soc., Perkin Trans. 1 2002, 895-900
5. Breeden, D. C.; Coates, R. M. Tetrahedron 1994, 50, 11123-11132
6. Rieger, J. M.; Brown, M. L.; Sullivan, G. W.; Linden, J.; Macdonald, T. L. J. Med. Chem. 2001, 44, 531-539
7. Müller, S.; Liepold, B.; Roth, G. J.; Bestmann, H. J. Synlett 1996, 521-522
8. Van Horn, D. E.; Negishi, E. J. Am. Chem. Soc. 1978, 100, 2252-2254
9. Negishi, E.; Kondakov, D. Y.; Choueiry, D.; Kasai, K.; Takahashi, T. J. Am. Chem. Soc. 1996, 118, 9577-9588
10. Lipshutz, B. H.; Butler, T.; Lower, A. J. Am. Chem. Soc. 2006, 128, 15396-15398
11. Pereira, S.; Srebnik, M. Organometallics 1995, 14, 3127-3128
12. See, for example: Lipshutz, B. H.; Butler, T.; Lower, A.; Servesko, J. Org. Lett. 2007, 3737-3740
13. Zhang, S.; Xu, L.; Trudell, M. L. Synthesis 2005, 16, 1757-1760
14. Nicolaou, K. C.; Sarlah, D.; Shaw, D. M. Angew. Chem., Int. Ed. 2007, 46, 4708-4711
15. Nicolaou, K. C.; Wu, T. R.; Sarlah, D.; Shaw, D. M.; Rowcliffe, E.; Burton, D. R. J. Am. Chem. Soc. 2008, 130, 11114-11121
16. Freskos, J. N.; Laneman, S. A.; Reilly, M. L.; Ripin, D. H. Tetrahedron Lett. 1994, 35, 835-838
17. Conditions of separation of dienophiles: Hypercarb column; eluant: water + 0.1% formic acid/MeOH + 0.1% formic acid 10/90.
18. Enders, D.; Kipphart, H.; Gerdes, P.; BrenaValle, L. J.; Bhushan, V. Bull. Soc. Chim. Belg. 1988, 97, 691-704
19. In our case, the observed de (determined by HPLC) for the enamine-mediated Michael addition of (S)-citronellal 13 and (R)-citronellal 17 to methyl vinyl ketone were disappointing (60% de from 13 and 56% de from 17).
20. The catalyst derived from (R)-proline should give (1′ S,4 R)- 14 and (1′ R,4 R)- 18 as major isomers, precursors of dienophiles 16 and 19.
21. Al-Zoubi, R. M.; Marion, O.; Hall, D. G. Angew. Chem., Int. Ed. 2008, 47, 2876-2879
22. Boger, D. L.; Patel, M J. Org. Chem. 1984, 49, 4099-4101
23. Ratios of these compounds were determined by HPLC.
24. 2O + 0.1% TFA 10/70/20.
25. Quian, J.; Voorbach, M. J.; Huth, J. R.; Coen, M. L.; Zhang, H.; Ng, S.-C.; Comess, K. M.; Petros, A. M.; Rosenberg, S. H.; Warrior, U.; Burns, D. J. Anal. Biochem. 2004, 328, 131-138
26. Cheng, Y. C.; Prussof, W. H. Biochem. Pharmacol. 1973, 22, 3099-3108